Specialty Pharmacy

The second of 4-part interview with an infectious disease expert examines weighing the short-term high cost of treating HCV with curative drugs versus the long-term costs of treating the disease.

Mark Wainberg, PhD was an influential researcher from the start of the AIDS epidemic.

College-educated Hispanic patients had a lower risk of poor mental quality of life, study shows.

Dexamethasone or rapamycin may raise blood glucose to dangerous levels, leading to healthy cell death.

Study suggests funding cuts to the National Institutes of Health could delay new treatments for neurological diseases that reduce spending.

Mark A. Vineis, vice president of Specialty Pharmacy at Cardinal Health, discusses how specialty pharmacies can help achieve the goals of accountable care organizations.

Individuals susceptible to hepatitis infection may also be susceptible to Parkinson’s disease.

Top news of the day from across the health care landscape.

Part 1 of a 4-part interview with an infectious disease expert explores treatment advances in HIV since the AIDS epidemic in the 1980s.

New technique determines whether cells have been exposed to a cancer-causing toxin.

Employing proteogenomics helps identifies therapeutic targets in breast cancer.

Nearly 70% of patients with HIV take dietary supplements with their antiretroviral therapy.

Program simulates the physiology of the human body to provide a response model to diseases, medications, and chemicals.

Women given vitamin D3 and calcium supplements had a 30% lower risk of cancer.

Top news of the day from across the health care landscape.

Attendees at the 2017 Asembia Specialty Pharmacy Summit will feature a robust lineup of sessions to obtain pharmacy CE credits.

Determining the composition of HIV’s glycoprotein can help fight the virus.

Legislation would allow community pharmacies to participate in Part D networks if they accept regulations and conditions that other in-network pharmacies operate within.

Selective androgen receptor degraders show promise as treatment for castration-resistant prostate cancer.

Under the ruling, Biogen secured Tecfidera exclusivity through 2028.

Top news of the day from across the health care landscape.

Findings may explain why some patients with cancer respond to immunotherapy while others do not.

CMS seeks to support flexibility and efficiency in Medicare Advantage and Part D plans.

A growing number of specialty pharmacy contractual agreements with payers and manufacturers have patient satisfaction metrics built in.

Optimized program can boost adherence and improve reporting capabilities to manufacturers.

After a prolonged court battle, Abu-Jamal will begin treatment for HCV in prison.

Novel drug delivery system steadily releases preventive HIV drugs over an extended period of time.

An artificial intelligence platform detected 92.4% of breast cancer tumors.